Others taper down
Furthermore, it is being investigated for its potential use in chronic weight management, reducing the risk of major adverse cardiovascular events, and managing other conditions such as heart failure with preserved ejection fraction, obesity, and non-cirrhotic non-alcoholic steatohepatitis.The Phase 3 SURPASS 1-5 clinical trial program was conducted to evaluate the safety and effectiveness of tirzepatide, which was administered once weekly through subcutaneous injections at different doses (5, 10, and 15 mg)
Is one safer than the other
Moreover, now getting attention for chronic weight management and loss
Husain M, Birkenfeld AL, Donsmark M, et al
The shelf life of compounded tirzepatide depends entirely on the formulation, the compounding conditions, and the specific pharmacy that prepared it